BioSeeker™: Discovery Reimagined for the Speed of Disease
the moonshot
Diseases, Existing and Emerging, Outpace Traditional Development.
The bottleneck isn’t biology. It’s discovery.
Infectious diseases are evolving faster, spreading farther, and growing deadlier. Outbreak frequency has more than tripled in recent decades, while global mobility and zoonotic spillover fuel constant new threats. Yet development remains stuck in a decade-long cycle. Even with billions invested, most of the time and cost in therapeutic and diagnostic R&D is spent before a product ever reaches a patient.
We didn’t just ask questions—we built the engine.
The breakthrough
Meet BioSeeker™: The Intelligence Engine Behind Seek Labs' Dual Technology Platforms
One engine. Two frontlines. Powered by BioSeeker.
BioSeeker powers everything we do. It rapidly identifies, ranks, and optimizes genetic targets for both diagnostics and therapeutics—compressing timelines and increasing precision across Seek Labs’ full-stack development processes.
Learn more about how BioSeeker powers our dual technology platforms.
BioSeeker integrates genomic data, machine learning, and continuous monitoring to power rapid, high-precision target discovery.
Automated scanning of pathogen genomes
High-impact, low-mutation-risk target ranking
CRISPR guide optimization for PTAP
Primer/probe design for SeekIt™
Pan-pathogen and strain-specific targeting
Every result feeds back into BioSeeker—strengthening future predictions, improving accuracy, and enabling continuous discovery at global scale
Turning Intelligence into Action, One Target at a Time
Global Therapeutic Atlas
Powered by BioSeeker™
At the heart of Seek Labs’ therapeutic pipeline is the Global Therapeutic Atlas—a continuously updated map of high-impact genetic targets across zoonotic, pandemic, and drug-resistant diseases. Designed as both an internal R&D engine and a collaboration resource, the Atlas informs rapid response readiness, strategic partnerships, and stockpile prioritization around the world.
From Sequence to Solution
How It Works
AI-Powered Genome Scanning: BioSeeker ingests and analyzes pathogen genomes across human and animal disease targets.
Target Prioritization: Machine learning models evaluate target conservation, function, off-target risk, and therapeutic/diagnostic value.
Therapeutics: CRISPR guides are optimized for PTAP constructs—supporting single or multiplexed ablation.
Diagnostics: Primer/probe sets are generated and scored for specificity, speed, and multiplex capacity.
Target designs are validated through in vitro, in vivo, or field studies—with BioSeeker learning from every result to strengthen future predictions.
In therapeutics, this accelerated workflow allows Seek Labs to move from target sequence to CRISPR vector to preclinical candidate in a matter of weeks, radically reducing time, cost, and risk.
A Smarter Discovery Engine Built for Partnerships
BioSeeker transforms discovery from a scientific bottleneck into a commercial engine. This isn’t just automation for automation’s sake—it’s precision at global scale. Collaborators can gain access to BioSeeker’s real-time discovery outputs, enabling faster development, broader protection, and de-risked R&D pipelines.
In addition to powering CRISPR-based therapeutics, BioSeeker also supports the development of alternative genetic therapies such as siRNA and antisense oligonucleotides (ASOs)—offering flexible solutions for a broad range of partners and modalities.
Diagnostics Developers
Want smarter, faster assays? BioSeeker builds multiplexable, field-ready primer/probe sets.
Investors & Funders
Want scalable, validated, IP-backed pipelines? BioSeeker is the discovery engine behind Seek Labs' dual-platform model.
Biotech & Pharma
Need faster, validated targets? BioSeeker delivers guide-ready sequences for your next therapeutic.
Government & NGOs
Need sovereign-ready tools and global reach? BioSeeker prioritizes targets for your mission.
Bold Collaborators
If you believe disease should be outsmarted, not just treated—we’re building the future with you in mind.
Why it matters
Discovery isn’t just the first step—it’s the difference between being ready and being too late
BioSeeker helps solve some of the hardest problems in global health by unlocking the right targets, faster. That means faster development of lifesaving therapeutics, smarter diagnostics, and better outcomes for people everywhere. BioSeeker is particularly valuable for diseases affecting underserved populations—where traditional discovery tools are too slow, costly, or limited by access to data.
Patients
Faster access to treatments and tests—especially for diseases that have long been overlooked or underfunded.
Clinicians
Clear, accurate tools that support timely decisions—whether in a hospital, rural clinic, or outbreak zone.
Communities
Early detection and targeted intervention before disease spreads—especially in regions with limited infrastructure.
Public Health
Actionable intelligence to get ahead of outbreaks—with plug-and-play targets ready before the next pandemic begins.
R&D
A discovery platform that reduces trial-and-error—making it easier to build solutions that actually reach the people who need them.